The pioneering trio will be joining us at Probiota Americas in Chicago to present their companies and network with the industry.
The core technology of Calgary, Alberta-based Nimble Science is the SIMBA GI Health Platform to access multi-omic data of the gut. The platform is empowered by the company’s innovate SIMBA capsule, a small ingestible capsule that can autonomously collect and preserve an uncontaminated small intestine fluid biopsy.
The collected sample allows a broad range of assays to reveal the diet-microbiota-host interrelationships and track our gut health.
The SIMBA capsule’s safety and efficacy have been validated by over 500 ingestions in multiple clinical studies, said the company, and that number is growing every day.
“The capsules are pumping out novel microbiome and metabolomic data showing the significant difference between small intestine and fecal samples,” explained the company.
“The relatively low-cost sampling technology will make our products affordable to everyone, from corporate and academia customers to consumers.
“As a discovery platform, it will enable the discovery of novel biomarkers and will enhance the knowledge of probiotic-host interrelationships, microbiota ecology, metabolism, and signaling in situ. These advancements have the potential to lead to significant commercial outcomes in multiple areas such as diagnostics and therapeutic management of a broad range of diseases, and personalized GI health monitoring and food management.”
We stay in Canada for our second 2023 Pioneer: Purity-IQ, a biotechnology company founded in November 2019 working with leading-edge genomic and nuclear magnetic resonance (NMR) technologies for identity and consistency testing of natural health products, quantification of biomolecules of interest, probiotic viable count enumeration, and more.
In the probiotic space, PIQ uses real-time polymerase chain reaction (qPCR)-based methods for probiotic strain identification and enumeration. In addition, species identification of botanicals in probiotic blends, pre-, pro-, and post-biotic product consistency testing are rendered through NMR metabolomics-based chemical fingerprinting and multivariate statistical analyses.
“In addition to these services, Purity-IQ offers customized research and development services, a tailored approach to address the growing need for innovation in the industry,” explained Dr. Hanan Shehata, Purity-IQ Senior Scientist.
“The projects are designed to address research questions pertaining to pre-, pro-, and post-biotic products and provide advanced analytics and insights that support the industry needs.”
Our third Pioneer is Tiny Health: The first microbiome platform that aims to prevent and correct infant gut imbalances in the critical first 1,000 days that may lead to eczema, allergies, asthma, obesity, and other chronic diseases later in life.
“Using shotgun metagenomic sequencing and proprietary AI models, we deliver evidence-based and actionable recommendations based on personalized microbiome profiles to parents, practitioners and research partners,” explained Cheryl Sew Hoy, CEO and Founder.
While the baby and pregnancy at-home tests are core products, Tiny Health also has a vaginal test for women and gut health test for children and adults.
“Our fully interactive web results portal come with evidence-based recommendations, so the entire family can optimize their gut health, where 80% of the immune system lives,” added Cheryl.
The event takes place June 14-16, 2023, at the Westin Chicago River North in Chicago. The three-day program will explore the state of the market, with insight from CEOs and from SPINS, postbiotics, how plant breeding can impact the human gut microbiome, the regulatory landscapes for microbiome modulators in the US and Canada, the opportunity with pets, disruptive technologies like CRISPR, A.I., and -omics, microbiome modulation to support women’s health, and LBPs in the USA.
Experts from NOW Health Group, Nouri, Postbiotics+, Microba, the University of Nebraska, the US Food & Drug Administration, Health Canada, Amin Talati Wasserman, the International Probiotics Association, the Broad Institute of MIT and Harvard, North Carolina State University, Synbiotic Health, Zbiotics, Morinaga, Kaneka, IFF, Fonterra, the National Animal Supplement Council, AnimalBiome, Persephone Pharma, ExeGi Pharma, University of São Paulo Medical School, and more.
Probiota 2023 in Barcelona was sold-out, so don’t wait to reserve your spot for the leading annual event for the prebiotic, probiotic and the microbiota focused food and pharma industries across the Americas. Register today for Probiota Americas.